A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors
Clinical trial NCT07170787 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07170787
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2029-02-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.